Medtronic plc has revealed the compensation package for Gary Corona, appointed as interim Chief Financial Officer effective August 3, 2024. The Compensation Committee approved a bi-weekly cash stipend of $12,500 and an equity grant of 8,966 time-based restricted stock units (RSUs) on August 15, 2024.The RSUs will vest over two years, with 50% vesting annually on the first and second anniversaries of the grant date. Corona's existing compensation, including a $500,000 annual base salary, 70% target bonus, and $1 million long-term incentive grant from July 29, 2024, remains unchanged.This amendment to the June 26, 2024 report provides additional details on Corona's compensation as interim CFO, demonstrating Medtronic's commitment to transparent disclosure of executive compensation arrangements.

Medtronic plc has revealed the compensation package for Gary Corona, appointed as interim Chief Financial Officer effective August 3, 2024. The Compensation Committee approved a bi-weekly cash stipend of $12,500 and an equity grant of 8,966 time-based restricted stock units (RSUs) on August 15, 2024.The RSUs will vest over two years, with 50% vesting annually on the first and second anniversaries of the grant date. Corona's existing compensation, including a $500,000 annual base salary, 70% target bonus, and $1 million long-term incentive grant from July 29, 2024, remains unchanged.This amendment to the June 26, 2024 report provides additional details on Corona's compensation as interim CFO, demonstrating Medtronic's commitment to transparent disclosure of executive compensation arrangements.